Non-Viral <i>Sleeping Beauty</i> Transposon Engineered CD19-CAR-NK Cells Show a Safe Genomic Integration Profile and High Antileukemic Efficiency
Tobias Bexte(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Veronika Gebel(Goethe University Frankfurt), Lacramioara Botezatu(German Cancer Research Center), Winfried S. Wels(Goethe University Frankfurt), Zoltán Ivics(German Cancer Research Center), Julia Campe(Goethe University Frankfurt), Lisa Marie Reindl(Goethe University Frankfurt), Michael Hudecek(Lighthouse Guild), Csaba Miskey(German Cancer Research Center)
Cited by 14
Related Papers
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
|Cancer Immunology Research|2014|517
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
|JCI Insight|2019|192
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2020|142
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119